Pfizer CentreOne

What Pfizer CentreOne does

Pfizer CentreOne is the contract manufacturing organization (CMO) arm of Pfizer Inc., providing commercial-scale pharmaceutical manufacturing services to enterprise pharmaceutical and biotechnology clients. Founded circa 1984, the business operates 11+ manufacturing sites across the United States (McPherson, Pearl River, North Creek/Bothell, Sanford) and Europe (Ascoli Piceno, Freiburg, Newbridge, Algete, Puurs, Strängnäs, Zagreb), spanning oral solid dose, sterile injectables, antibody-drug conjugates (ADCs), and microbial fermentation. Its technology stack includes aseptic fill-finish, lyophilization, pre-filled syringe manufacturing, high-containment processing (OEB 1-5), single-use ADC conjugation, and mammalian cell culture, supported by a proprietary Integrated Manufacturing Excellence (IMEx) operating system and a structured seven-phase tech transfer methodology.

Pfizer CentreOne generates revenue through fee-for-service, multi-year contract manufacturing agreements with three primary customer segments: large pharmaceutical companies, biotechnology companies (with a particular focus on ADCs and complex biologics), and generic pharmaceutical manufacturers. Pricing is quote-based and project-specific, with no public price list. The go-to-motion is enterprise field sales — dedicated business development leads, portfolio leads, and account management — supplemented by thought leadership content (whitepapers, webinars, podcasts, case studies) and presence at BIO, CPHI, Contract Pharma, and BIO-Europe. The franchise is differentiated by regulatory coverage across 150+ countries, a 40+ year CMO track record, 8 consecutive years of CDMO Leadership Awards (2017–2024), and the heritage of producing the world's first commercially approved ADC (Mylotarg). Pfizer CentreOne does not disclose standalone revenue, operates without separate external funding, and is wholly owned by Pfizer Inc. (NYSE: PFE).

Name

Pfizer CentreOne

Legal name

Pfizer Inc.

Website

https://pfizercentreone.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

101–250 employees

Short description

Pfizer CentreOne is the contract manufacturing arm of Pfizer Inc., offering commercial-scale oral solid dose, sterile injectable, antibody-drug conjugate, and microbial fermentation services to pharmaceutical and biotechnology companies across 150+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

GMP Manufacturing Support Services (QA/QMS, validation, documentation) (HLAAAKAH), Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Contract pharmaceutical manufacturing
• Sterile injectable manufacturing
• Oral solid dose manufacturing
• Antibody-drug conjugate manufacturing
• Pharmaceutical tech transfer services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Pfizer CentreOne generates revenue through fee-for-service contract manufacturing agreements with pharmaceutical and biotech companies. Services include manufacturing of oral solid dose, sterile injectables, antibody-drug conjugates, and biologic drug products. Revenue is project-based with pricing negotiated per contract, typically covering development, manufacturing, fill-finish, and regulatory support services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels10 records

Core offering

Pfizer CentreOne is a contract manufacturing organization (CMO) that provides pharmaceutical and biotech companies with commercial-scale manufacturing services for oral solid dose (OSD) drugs, sterile injectables, antibody-drug conjugates (ADCs), and microbial fermentation products. The services span late-stage clinical through commercial production, supported by technology transfer expertise, regulatory support across 150+ countries, and IP protection frameworks, all delivered through Pfizer's global manufacturing network.

Product overview

Pfizer CentreOne is an award-winning Contract Manufacturing Organization (CMO) offering a comprehensive portfolio of pharmaceutical manufacturing services powered by Pfizer's global network. The company provides three core manufacturing service lines—Oral Solid Dose (OSD), Sterile Injectables, and Antibody-Drug Conjugates (ADC)—supported by dedicated manufacturing networks across multiple global sites. The product portfolio also includes Microbial Fermentation, Tech Transfer Services, Regulatory Support, and IP Protection. These services are integrated under Pfizer CentreOne's unified offering, where manufacturing capabilities span from late-stage clinical through commercialization, leveraging shared regulatory expertise across 150+ countries and Pfizer's infrastructure of over $1B annual manufacturing investment.

Differentiator

Problem solved

Functional benefit

Products and services

• Oral Solid Dose (OSD) Manufacturing Services Contract manufacturing of oral solid dose drug products including pellets, tablets, and capsules, supporting immediate-release and modified-release profiles (prolonged, delayed, and multiphase). Capabilities span dry granulation, wet granulation, extrusion/spheronization, compression, encapsulation, coating, and packaging, with high-containment facilities handling OEB 1-5 highly potent compounds. Built for pharmaceutical and biotech customers requiring commercial-scale OSD supply across global markets.
• Sterile Injectables Manufacturing Services Contract manufacturing of sterile injectable drug products including liquid and lyophilized formulations, aseptic fill-finish, and terminal sterilization. Container closure options include glass vials (2-100mL), pre-filled syringes (1-5mL), cartridges, and ampoules, with advanced aseptic filling using isolator and RABS technology. Built for pharmaceutical and biotech customers needing commercial-scale sterile injectable capacity across biologics, small molecules, combination products, and vaccines.
• Antibody-Drug Conjugate (ADC) Manufacturing Services End-to-end ADC manufacturing services from mammalian cell culture through conjugation, purification, formulation, and fill-finish, supported by over two decades of experience and purpose-built facilities at Pearl River, NY and North Creek (Bothell), WA. The Pearl River site provides ~24,000 sq.ft for highly potent and cytotoxic ADC processing, while North Creek offers 51,000 sq.ft with advanced single-use technologies for clinical and commercial cGMP manufacturing. Designed for biotech and pharma partners developing novel antibody-drug conjugates.
• Microbial Fermentation Services Contract microbial fermentation for vaccines, growth hormones, and biologic drug substances, with advanced harvest and purification technologies. The Strängnäs site has 70+ years of manufacturing experience supported by 370+ Pfizer experts, and the Zagreb site has 13+ years of biologics drug substance and drug product manufacturing experience on an 11-acre campus. Built for pharmaceutical and biotech customers requiring microbial-derived biologics.
• Pharmaceutical Tech Transfer Services Technology transfer services supporting seamless transitions from clinical to commercial manufacturing, using a structured, unified approach covering geographic footprint, technology, personnel, regulatory compliance, collaboration, and quality. Leverages digital infrastructure, deep regulatory expertise across 150+ countries, and coordinated global teams. Built for pharmaceutical and biotech partners scaling manufacturing programs.
• Regulatory Support and IP Protection Services End-to-end regulatory affairs support for submissions across 150+ countries, backed by a regulatory team with 80+ years of combined experience and inspection credentials at FDA, EMA, PMDA, MHRA, Health Canada, ANVISA, NMPA, TGA, and other agencies. IP protection is delivered through Pfizer's security protocols and frameworks, providing peace of mind, reliability, and uncompromising quality for partners' outsourced manufacturing programs.

Quantifiable outcome

• Over 90% on-time, in-full (OTIF) delivery with no issues on audit
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators13 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Lonza Group: Lonza is one of the world's largest contract development and manufacturing organizations, offering biologics, small molecules, and cell & gene therapy manufacturing — directly competing with Pfizer CentreOne across multiple modalities including ADCs and sterile injectables.
• Catalent: Catalent is a major global CDMO providing oral dose, sterile injectable, and biologic drug product manufacturing services to pharma and biotech customers — a direct competitor in OSD, sterile injectables, and tech transfer services.
• Samsung Biologics: Samsung Biologics is a leading contract manufacturer of biopharmaceuticals offering mammalian cell culture, fill-finish, and aseptic manufacturing services — competing directly for biologics and ADC contract manufacturing work.
• WuXi Biologics: WuXi Biologics provides end-to-end biologics contract manufacturing including cell line development, drug substance, and drug product services — a direct competitor for mammalian-based biologics and ADC manufacturing partnerships.
• Siegfried Holding: Siegfried is a Swiss-based CDMO specializing in oral solid dose and sterile injectable manufacturing for the pharmaceutical industry — directly comparable in OSD and API manufacturing services.
• AGC Biologics: AGC Biologics is a global biopharmaceutical contract manufacturer offering mammalian cell culture, microbial fermentation, and fill-finish services — directly competing for biologics and vaccine manufacturing programs.
• Recipharm: Recipharm is a European-based contract development and manufacturing organization focused on sterile injectables, oral solids, and inhalation products — directly comparable in OSD and sterile injectable contract manufacturing services.

Broad incumbents

• Boehringer Ingelheim BioXcellence: Boehringer Ingelheim's BioXcellence is a large biopharmaceutical contract manufacturing business offering mammalian and microbial biologics production — competing for ADC and biologics manufacturing opportunities with deeper parent-company R&D resources.
• FUJIFILM Diosynth Biotechnologies: FUJIFILM Diosynth is a major contract manufacturer of biologics including vaccines, monoclonal antibodies, and ADCs — a broad incumbent competing for the same biotech and pharma manufacturing partnerships.
• Thermo Fisher Scientific (Patheon): Thermo Fisher's pharma services business (including Patheon) provides comprehensive contract manufacturing, development, and clinical trial services — a broad incumbent offering OSD, sterile injectables, and biologics at scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pfizer-centreone

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pfizer CentreOne